Literature DB >> 7426550

Ophthalmic manifestations of primary oxalosis.

A R Fielder, A Garner, T L Chambers.   

Abstract

The clinical and pathological findings of a 6-month-old infant with primary oxalosis, who died in renal failure, are presented. The oxalate crystalline deposition in the retinal pigment epithelium corresponded to the flecked retinopathy observed ophthalmoscopically. The difficulties in establishing a precise biochemical diagnosis are discussed and the relevant ophthalmic literature is reviewed.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7426550      PMCID： PMC1043817          DOI： 10.1136/bjo.64.10.782

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  38 in total

1.  Urinary oxalate excretion.

Authors:  E F DEMPSEY; A P FORBES; R A MELICK; P H HENNEMAN
Journal:  Metabolism       Date:  1960-01       Impact factor: 8.694

2.  Calcium oxalate and calcium phosphate crystals in detached retinas.

Authors:  D G COGAN; T KUWABARA; J SILBERT; H KERN; V McMURRAY; C HURLBUT
Journal:  AMA Arch Ophthalmol       Date:  1958-09

3.  Calcium oxalate crystals within ocular tissues; a clinicopathologic and histochemical study.

Authors:  L E ZIMMERMAN; F B JOHNSON
Journal:  AMA Arch Ophthalmol       Date:  1958-09

4.  Observations on the anatomy and pathology of the choroidal vasculature.

Authors:  H G Ring; T Fujino
Journal:  Arch Ophthalmol       Date:  1967-10

5.  Retinal oxalosis.

Authors:  A Garner
Journal:  Br J Ophthalmol       Date:  1974-06       Impact factor: 4.638

6.  Deficiency of 2-oxo-glutarate: glyoxylate carboligase activity in primary hyperoxaluria.

Authors:  J Koch; E L Stokstad; H E Williams; L H Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1967-04       Impact factor: 11.205

7.  L-glyceric aciduria. A new genetic variant of primary hyperoxaluria.

Authors:  H E Williams; L H Smith
Journal:  N Engl J Med       Date:  1968-02-01       Impact factor: 91.245

8.  Hyperoxaluria in adults.

Authors:  M Cochran; A Hofhkinson; P M Zarembski; C K Anderson
Journal:  Br J Surg       Date:  1968-02       Impact factor: 6.939

9.  Flecked retina. Appearance secondary to oxalate crystals from methoxyflurane anesthesia.

Authors:  J D Bullock; D M Albert
Journal:  Arch Ophthalmol       Date:  1975-01

10.  Oxalosis and primary hyperoxaluria.

Authors:  E F SCOWEN; A G STANSFELD; R E WATTS
Journal:  J Pathol Bacteriol       Date:  1959-01
View more
  8 in total

1.  [Type I oxalosis in childhood--studies within the scope of terminal renal failure in the child].

Authors:  M Frosch; E Kuwertz-Bröking; M Bulla; D B von Bassewitz; D B Leusmann
Journal:  Klin Wochenschr       Date:  1989-11-17

Review 2.  Primary hyperoxaluria type I.

Authors:  K Latta; J Brodehl
Journal:  Eur J Pediatr       Date:  1990-05       Impact factor: 3.183

3.  A clinicopathological study of ocular involvement in primary hyperoxaluria type I.

Authors:  K W Small; J Scheinman; G K Klintworth
Journal:  Br J Ophthalmol       Date:  1992-01       Impact factor: 4.638

4.  New aspects of infantile oxalosis.

Authors:  E P Leumann; A Niederwieser; A Fanconi
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

5.  Bietti's tapetoretinal degeneration with marginal corneal dystrophy (crystalline retinopathy): case report.

Authors:  R J Harrison; R R Acheson; J C Dean-Hart
Journal:  Br J Ophthalmol       Date:  1987-03       Impact factor: 4.638

6.  Oxalosis in infancy.

Authors:  M C Morris; T L Chambers; P W Evans; P N Malleson; J R Pincott; G A Rose
Journal:  Arch Dis Child       Date:  1982-03       Impact factor: 3.791

Review 7.  Update on oxalate crystal disease.

Authors:  Elizabeth C Lorenz; Clement J Michet; Dawn S Milliner; John C Lieske
Journal:  Curr Rheumatol Rep       Date:  2013-07       Impact factor: 4.592

8.  Experimental calcium oxalate retinopathy compared with cystine- and tyrosine-induced retinal damage. An ophthalmoscopical, histological, and electrophysiological study.

Authors:  U Weber; H U Sons; R Hennekes; W Lenz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.